GC WellBeing Corporation (KOSDAQ:234690)

South Korea · Delayed Price · Currency is KRW

11,180

+1,270 (12.82%)

At close: Oct 1, 2026

GC WellBeing Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	192,210	164,680	133,805	120,535
Revenue Growth	35.53%	23.08%	11.01%	-
Gross Profit	78,714	73,317	64,761	62,738
Operating Income	17,537	17,294	12,964	10,457
Net Income	5,490	10,011	7,069	6,748
Earnings Per Share	269.01	486.11	398.00	380.11
EPS Growth	-39.87%	22.14%	4.71%	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Prescription Drugs	158,468	134,208	108,442	102,953
Health Functional Food	35,603	32,803	26,413	17,581
Unallocated Adjutment	-	-2,331	-1,050	-
Total	192,210	164,680	133,805	120,535

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	3,922	3,906	3,104	2,403
Total Debt	89,718	75,488	33,641	36,501
Net Cash (Debt)	-85,796	-71,582	-30,537	-34,098
Net Cash Growth	-	-	-	-
Net Cash Per Share	-4552.47	-3651.96	-1720.61	-1920.76

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-6,346	5,730	13,710	-1,030
Capital Expenditures	-4,356	-3,695	-1,491	-941.06
Free Cash Flow	-10,702	2,035	12,219	-1,971
Free Cash Flow Growth	-	-83.35%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Gross Margin	40.95%	44.52%	48.40%	52.05%
Operating Margin	9.12%	10.50%	9.69%	8.68%
Pretax Margin	3.64%	7.64%	7.13%	6.84%
Profit Margin	2.86%	6.08%	5.28%	5.60%
FCF Margin	-5.57%	1.24%	9.13%	-1.64%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	140.000	140.000	120.000	100.000
Dividend Per Share Growth	0%	16.67%	20.00%	-
Dividend Yield	1.25%	1.55%	1.20%	1.26%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
PE Ratio	41.56	16.20	25.26	21.39
Forward PE	25.18	8.77	-	-
P/FCF Ratio	-	79.71	14.62	-
PS Ratio	1.04	0.99	1.34	1.20